IGC Pharma Inc (IGC)

Currency in USD
0.3395
+0.0005(+0.15%)
Closed·
After Hours
0.3354-0.0041(-1.21%)
·
IGC Scorecard
Full Analysis
Quickly burning through cash
IGC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.33000.3399
52 wk Range
0.25250.4800
Key Statistics
Prev. Close
0.339
Open
0.334
Day's Range
0.33-0.3399
52 wk Range
0.2525-0.48
Volume
288.77K
Average Volume (3m)
2.59M
1-Year Change
-13.17%
Book Value / Share
0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IGC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.8750
Upside
+1,041.38%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

IGC Pharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

IGC Pharma Inc Company Profile

IGC Pharma, Inc., a clinical stage pharmaceutical company, develops treatments for Alzheimer’s disease in the United States and Colombia. The company’s lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer’s. Its pre-clinical stage product candidate includes TGR-63, IGC-M3, and LMP to treat Alzheimer’s disease; IGC-1C for the treatment of metabolic disorders and Alzheimer’s disease; and IGC-1A to treat metabolic disorders. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.

Compare IGC to Peers and Sector

Metrics to compare
IGC
Peers
Sector
Relationship
P/E Ratio
−4.0x−1.3x−0.5x
PEG Ratio
−0.070.030.00
Price/Book
4.5x0.3x2.6x
Price / LTM Sales
22.4x1.2x3.3x
Upside (Analyst Target)
-230.5%43.5%
Fair Value Upside
Unlock10.9%6.8%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.8750
(+1,041.38% Upside)

Earnings

Latest Release
Aug 08, 2025
EPS / Forecast
-- / -0.025
Revenue / Forecast
-- / 326.00K
EPS Revisions
Last 90 days

IGC Income Statement

People Also Watch

2.070
VOR
0.00%
18.23
SRPT
+1.50%
0.547
WINT
-6.81%
5.0100
CLDI
-13.02%
0.04
GIBO
0.00%

FAQ

What Stock Exchange Does IGC Pharma Trade On?

IGC Pharma is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for IGC Pharma?

The stock symbol for IGC Pharma is "IGC."

What Is the IGC Pharma Market Cap?

As of today, IGC Pharma market cap is 28.48M.

What Is IGC Pharma's Earnings Per Share (TTM)?

The IGC Pharma EPS (TTM) is -0.09.

When Is the Next IGC Pharma Earnings Date?

IGC Pharma will release its next earnings report on 11 Nov 2025.

From a Technical Analysis Perspective, Is IGC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has IGC Pharma Stock Split?

IGC Pharma has split 1 times.

How Many Employees Does IGC Pharma Have?

IGC Pharma has 70 employees.

What is the current trading status of IGC Pharma (IGC)?

As of 09 Aug 2025, IGC Pharma (IGC) is trading at a price of 0.34, with a previous close of 0.34. The stock has fluctuated within a day range of 0.33 to 0.34, while its 52-week range spans from 0.25 to 0.48.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.